Senior Manager, Pharmacovigilance
Abata TherapeuticsFull Time
Senior (5 to 8 years)
Key technologies and capabilities for this role
Common questions about this position
This is a contractor position for Senior Manager, Pharmacovigilance.
This information is not specified in the job description.
Candidates need an MD with 4+ years of pharmacovigilance or drug safety experience, strong knowledge of global regulations (FDA, EMA, ICH), proficiency in MS Office and Oracle ARGUS Safety Database, leadership ability, excellent communication, and detail-orientation.
Eikon values collaboration, uncompromising integrity, conscientiousness, obsessive attention to detail, documentation, organization, and self-starters in a team-oriented environment focused on drug discovery.
A strong candidate is a pharmacovigilance expert with an MD and 4+ years experience, analytical and detail-oriented mindset, passion for drug discovery, strong regulatory knowledge, technical skills in ARGUS, and proven ability to lead independently while collaborating cross-functionally.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.